|
The North American Neuromodulation Society (NANS) and the Institute of Neuromodulation (ION) are investing in the next generation of neuromodulation researchers through the NANS/ION Early Stage Investigator (ESI) Research Grant.
0 Comments
NANS participated in the 2026 American Medical Association (AMA) House of Delegates Annual Meeting, held June 5–10 in Chicago, advancing advocacy efforts on behalf of patients, clinicians, and the neuromodulation field.
The North American Neuromodulation Society (NANS) has published a new consensus curriculum for deep brain stimulation (DBS) implantation training.
The North American Neuromodulation Society (NANS) is calling on UnitedHealthcare (UHC) to reconsider its policy denying coverage for implantable vagus nerve stimulation (iVNS) paired with rehabilitation for stroke recovery.
The North American Neuromodulation Society (NANS) has joined more than 100 medical organizations in a joint letter to federal agencies raising concerns about how the No Surprises Act (NSA) is being implemented.
The North American Neuromodulation Society (NANS), alongside several leading medical societies, recently submitted a joint letter to Elevance Health expressing concern over its policy classifying peripheral nerve stimulation (PNS) as investigational for the treatment of chronic pain.
NANS joined a coalition of leading medical societies in submitting formal comment letters to First Coast Service Options and Novitas regarding the proposed LCD for trigger point injections (TPIs).
NANS Applauds Aetna for Revising Policy on Peripheral Electrical Nerve Stimulation for Pain Policy3/29/2026 The North American Neuromodulation Society (NANS) recognizes Aetna for updating its clinical policy on peripheral electrical nerve stimulation (PNS) for pain, expanding access to non-pharmacological treatment options for patients with chronic pain.
The North American Neuromodulation Society (NANS) has opened the public comment period for its draft Clinical Guideline on Implantable Peripheral Nerve Stimulation (PNS) for Chronic Pain—one of the first formal guideline initiatives undertaken by the Society.
The North American Neuromodulation Society (NANS) joined several leading medical specialty societies in submitting joint letters to Cigna Healthcare and UnitedHealthcare regarding policies that classify peripheral nerve stimulation (PNS) as investigational for the treatment of chronic pain.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
July 2026
Categories |
RSS Feed